BioCentury
ARTICLE | Clinical News

AAD-2004: Phase I started

September 6, 2010 7:00 AM UTC

Neurotech began a double-blind, placebo-controlled Phase I trial to evaluate AAD-2004 in 32 healthy volunteers. ...